Articles, App Notes, Case Studies, & White Papers

31. Why Advanced cGMP Manufacturing Is Key to Pharma Success 1/26/2026

    Advanced cGMP facilities deliver control, expertise, and reliable processes that protect quality and support smooth progress to market. Strong partnerships help reduce risk in complex programs.

32. Overcoming Inventory Challenges For A Complex, Global Study 7/14/2022

    Explore how the optimization of Interactive Response Technologies (IRT) settings relieved the burden of managing global supply needs for a CRO customer and clinical sponsor.

33. Building A Flexible, Challenge Resistant, Patient-Centric Clinical Supply Chain

    Flexible solutions, like demand-led supply and direct-to-patient distribution, are helping sponsors address the growing list of challenges presented by today’s increasingly complex studies.

34. 5 Tips To Put The Right Systems In Place For Successful Clinical Trials 7/11/2025

    Before you dive into clinical trials, ask yourself: Is my company operationally ready to handle the complexity? Learn about key upgrades that can help you streamline operations and reduce risk.

35. Clinical, Commercial Packaging: Delivering Next-Gen Therapies 4/7/2026

    See how strategic, agile, and sustainable packaging is transforming drug delivery into a key driver of speed, safety, and patient-centric innovation.

36. Common RTSM/IRT AN Medication Pooling Questions Answered 11/21/2024

    Whether you’re planning a single trial or an entire program, medication pooling offers a pathway to cost-effective and sustainable clinical trial management.

37. How To Evaluate A Clinical Supply Chain Partner To Meet Vaccine Trial Needs 1/1/2022

    When selecting a supply chain partner, due diligence is critical. This article highlights questions you should be asking to ensure you are selecting the right supply chain partner for your clinical trial needs.

38. The Crucial Role Of IRT/RTSM In Optimizing Drug Supply Budgets 10/4/2024

    Expand your knowledge of IRT/RTSM systems and their capabilities to tailor supplies to site-specific recruitment, significantly decrease drug waste and costs, ensure efficient IMP management, and more.

39. Sample Sizes For Performance Testing Of Combination Products, Packaging 5/16/2025

    When developing combination products or evaluating primary packaging for drug products one must evaluate the performance of the devices and the packaging to ensure that they are fit-for-purpose.

40. Bringing A Biosimilar For Oncology To Market: Injectable Packaging From Early Development To Commercialization 2/20/2024

    While in their early-stage development of a mAb biosimilar for oncology treatment, a large biopharmaceuticals company sought a packaging recommendation: a stopper to maintain high-quality standards.